119 related articles for article (PubMed ID: 3308290)
21. IDEC-C2B8 anti-CD20 (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: evaluation of response on 48 patients.
Nguyen DT; Amess JA; Doughty H; Hendry L; Diamond LW
Eur J Haematol; 1999 Feb; 62(2):76-82. PubMed ID: 10052709
[TBL] [Abstract][Full Text] [Related]
22. The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis.
Miller ML; Fishleder AJ; Tubbs RR
Am J Clin Pathol; 1991 Jul; 96(1):100-8. PubMed ID: 2069128
[TBL] [Abstract][Full Text] [Related]
23. A sensitive method for immunophenotyping stored leukemia and lymphoma cells with preservation of morphological detail.
Lowenthal RM; Pralle H; Matter HP
Pathology; 1985 Jul; 17(3):481-7. PubMed ID: 3906523
[TBL] [Abstract][Full Text] [Related]
24. Immunological types of lymphoproliferative disorders in a cohort: a 4-year study.
Lowenthal RM; Sawyer PJ; Lickiss JN; Harlow RW; Kirov SM; Woods GM
Aust N Z J Med; 1982 Aug; 12(4):258-62. PubMed ID: 6814410
[TBL] [Abstract][Full Text] [Related]
25. Expression of the CD11c antigen in B-cell chronic lymphoproliferative disorders.
Marotta G; Raspadori D; Sestigiani C; Scalia G; Bigazzi C; Lauria F
Leuk Lymphoma; 2000 Mar; 37(1-2):145-9. PubMed ID: 10721778
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric characterization of chronic lymphocyte leukaemias using orthogonal light scattering and quantitative immunofluorescence.
Terstappen LW; de Grooth BG; van Berkel W; ten Napel CH; Greve J
Blut; 1988 May; 56(5):201-8. PubMed ID: 3285911
[TBL] [Abstract][Full Text] [Related]
27. Use of the monoclonal antibody WR17, identifying the CD37 gp40-45 Kd antigen complex, in the diagnosis of B-lymphoid malignancy.
Moore K; Cooper SA; Jones DB
J Pathol; 1987 May; 152(1):13-21. PubMed ID: 3305845
[TBL] [Abstract][Full Text] [Related]
28. Immunogold-silver technique applied to showing malignant B cell infiltration of gastrointestinal tract in patients with chronic lymphocytic leukaemia and non-Hodgkin's lymphoma.
Smith G; Crocker J; Nar P; Chesner I; Leyland MJ
J Clin Pathol; 1987 Jul; 40(7):756-9. PubMed ID: 3114328
[TBL] [Abstract][Full Text] [Related]
29. Lymphocytic lymphoma/B-chronic lymphocytic leukaemia--an immunohistopathological study of peripheral B lymphocyte neoplasia.
Swerdlow SH; Murray LJ; Habeshaw JA; Stansfeld AG
Br J Cancer; 1984 Nov; 50(5):587-99. PubMed ID: 6388614
[TBL] [Abstract][Full Text] [Related]
30. Immuno-histological diagnosis of lymphoproliferative diseases by selected combinations of antisera and monoclonal antibodies.
Janossy G; Thomas JA; Pizzolo G; Granger SM; McLaughlin J; Habeshaw JA; Stansfeld AG; Sloane J
Br J Cancer; 1980 Aug; 42(2):224-42. PubMed ID: 6775656
[TBL] [Abstract][Full Text] [Related]
31. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
[TBL] [Abstract][Full Text] [Related]
32. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
Tubbs RR; Fishleder A; Weiss RA; Savage RA; Sebek BA; Weick JK
Am J Pathol; 1983 Nov; 113(2):207-21. PubMed ID: 6605690
[TBL] [Abstract][Full Text] [Related]
33. Lymphoblastic lymphoma with the phenotype of common acute lymphoblastic leukemia.
Borowitz MJ; Croker BP; Metzgar RS
Am J Clin Pathol; 1983 Mar; 79(3):387-91. PubMed ID: 6338702
[TBL] [Abstract][Full Text] [Related]
34. Reactivity of the monoclonal antibody RFB1 in chronic B-cell leukaemias.
Melo JV; Catovsky D; Bodger M
Scand J Haematol; 1984 Apr; 32(4):417-22. PubMed ID: 6609424
[TBL] [Abstract][Full Text] [Related]
35. A study of lymphoproliferative diseases comparing immunofluorescence with immunohistochemistry.
Warnke R; Pederson M; Williams C; Levy R
Am J Clin Pathol; 1978 Dec; 70(6):67-75. PubMed ID: 103428
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte antibodies in leukaemic chronic lymphoproliferative disorders.
Rustagi PK; Han T; Ziolkowski L; Farolino DL; Currie MS; Logue GL
Br J Haematol; 1987 Aug; 66(4):461-5. PubMed ID: 3663502
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the lymphoproliferative diseases in the skin by DNA analysis.
Nakajima N; Tanaka T; Miyachi Y; Imamura S; Kakizuka A
J Dermatol; 1991 Nov; 18(11):627-34. PubMed ID: 1800528
[TBL] [Abstract][Full Text] [Related]
38. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
Huber H; Gattringer C; Thaler J; Peschel C
Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
[TBL] [Abstract][Full Text] [Related]
39. Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Differential diagnosis, prognosis as related to immunophenotype, and recommendations for testing.
Deegan MJ
Arch Pathol Lab Med; 1989 Jun; 113(6):606-18. PubMed ID: 2658905
[TBL] [Abstract][Full Text] [Related]
40. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.
Guy K; Krajewski AS; Dewar AE
Br J Cancer; 1986 Feb; 53(2):161-73. PubMed ID: 3513812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
